Issues With the Diagnosis and Classification of Hyperglycemia in Early Pregnancy
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
In 2010, the International Association of the Diabetes and Pregnancy Study Groups (IADPSG) panel published consensus-based recommendations on the diagnosis and classification of hyperglycemia in pregnancy (1). Within that document, the recommendations regarding early pregnancy testing were designed to facilitate early detection and treatment of hyperglycemia (HbA1c ≥6.5% [48 mmol/mol], fasting venous plasma glucose ≥7.0 mmol/L, random plasma glucose ≥11.1 mmol/L with confirmation) that, outside pregnancy, would be classified as diabetes. The term “overt diabetes” was suggested to describe these women. Subsequently, the World Health Organization (WHO) adopted the IADPSG criteria with some modifications and promoted the use of the term “diabetes in pregnancy” (2) for this group. Cognizant that milder degrees of hyperglycemia would also be detected by early pregnancy testing, the IADPSG also recommended that fasting …
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The International Association of the Diabetes and Pregnancy Study Groups (IADPSG) GDM diagnostic criteria for the 75-g OGTT, as well as the GDM screening and diagnostic criteria used in the two-step approach, were not derived from data in the fi rst half of pregnancy and should not be used for early screening (197).”
From 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2024 (2024) · cites this paper as [197]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The GDM diagnostic criteria for the 75-g OGTT from the International Association of the Diabetes and Pregnancy Study Groups (IADPSG) and the GDM screening and diagnostic criteria with the two-step approach were not derived from data in the first half of pregnancy”
From 2. Diagnosis and classification of diabetes: standards of care in diabetes-2025 (2025) · cites this paper as [179]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Untreated glucose intolerance increases the risk of maternal and neonatal complications.”
From Evolution of Gestational Diabetes Mellitus across Continents in 21st Century (2022) · cites this paper as [2]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Furthermore, different cut-off values of 5.1 mmol/L 92 mg/dL or 5.3 mmol/L 95 mg/dL for the 75 g OGTT were used [2].”
From Evolution of Gestational Diabetes Mellitus across Continents in 21st Century (2022) · cites this paper as [2]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Offspring whose mothers had GDM are more likely to be overweight, and obese, and they may develop glucose intolerance and type 2 diabetes mellitus (T2DM) in the future [2].”
From Evolution of Gestational Diabetes Mellitus across Continents in 21st Century (2022) · cites this paper as [2]
Experimental — accuracy not yet measured
5 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
International Association of Diabetes and Pregnancy Study Groups Consensus Panel (2010) · Diabetes Care · doi:10.2337/dc09-1848 · Cited by 5,390 · cited 1×
“In 2010, the International Association of the Diabetes and Pregnancy Study Groups (IADPSG) panel published consensus-based recommendations on the diagnosis and classification of hyperglycemia in pregnancy (1).”
BackgroundMetzger, B. E., Gabbe, S. G., Persson, B., Lowe, L. P., Dyer, A. R., Oats, J. J. N., & Buchanan, T. A. (2010) · Diabetes Care · doi:10.2337/dc10-0719 · Cited by 1,888
Zhu, W.-W., Yang, H.-X., Wei, Y.-M., Yan, J., Wang, Z.-L., Li, X.-L., Wu, H.-R., Li, N., Zhang, M.-H., Liu, X.-H., et al. (2013) · Diabetes Care · doi:10.2337/dc12-1157 · Cited by 338 · cited 4×
“Zhu WW, Yang HX, Wei YM, et al. Evaluation of the value of fasting plasma glucose in the first prenatal visit to diagnose gestational diabetes mellitus in China.”
BackgroundInfluentialHughes, R. C. E., Moore, M. P., Gullam, J. E., Mohamed, K., & Rowan, J. (2014) · Diabetes Care · doi:10.2337/dc14-1312 · Cited by 238
Colagiuri, S., Falavigna, M., Agarwal, M. M., Boulvain, M., Coetzee, E., Hod, M., Meltzer, S. J., Metzger, B., Omori, Y., Rasa, I., et al. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2014.02.012 · Cited by 132
Corrado, F., D’Anna, R., Cannata, M. L., Interdonato, M. L., Pintaudi, B., & Di Benedetto, A. (2012) · Diabetes & Metabolism · doi:10.1016/j.diabet.2012.03.006 · Cited by 96 · cited 2×
“More recent data from Italy (3) and China (4), where IADPSG diagnostic criteria were applied, have strongly challenged this recommendation, demonstrating a clear fall in FPG in early pregnancy and showing that early FPG $5.”
BackgroundInfluential
Cited by
2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2022
American Diabetes Association Professional Practice Committee (2022) · Diabetes Care · doi:10.2337/dc22-s002 · Cited by 4,792
“The International Association of the Diabetes and Pregnancy Study Groups (IADPSG) GDM diagnostic criteria for the 75-g OGTT as well as the GDM screening and diagnostic criteria used in the two-step approach were not derived from data in the first half of pregnancy and should not be used for early screening (218).”
Method2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2020
American Diabetes Association (2020) · Diabetes Care · doi:10.2337/dc20-s002 · Cited by 3,187
“diagnosticcriteria for the75-gOGTTaswell as the GDM screening and diagnostic criteria used in the two-step approach were not derived from data in the first half of pregnancy, so the diagnosis of GDM in early pregnancy by either FPG or OGTT values is not evidence based (134) and further work is needed.”
Method2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2018
American Diabetes Association (2018) · Diabetes Care · doi:10.2337/dc18-s002 · Cited by 3,159
“The International Association of the Diabetes and Pregnancy Study Groups (IADPSG) GDM diagnostic criteria for the 75-g OGTT as well as the GDM screening and diagnostic criteria used in the twostep approach were not derived from data in the first half of pregnancy, so the diagnosis of GDM in early pregnancy by either F…”
Method2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2021
American Diabetes Association (2021) · Diabetes Care · doi:10.2337/dc21-s002 · Cited by 3,116
“The International Association of the Diabetes and Pregnancy Study Groups (IADPSG) GDM diagnostic criteria for the 75-g OGTT as well as the GDM screening anddiagnostic criteriaused in the two-step approach were not derived from data in the first half of pregnancy, so the diagnosis ofGDMinearlypregnancybyeither FPGor OG…”
Method2. Classification and Diagnosis of Diabetes:Standards of Medical Care in Diabetes—2019
American Diabetes Association (2019) · Diabetes Care · doi:10.2337/dc19-s002 · Cited by 2,697
“OGTT as well as the GDM screening and diagnostic criteria used in the twostep approach were not derived from data in the first half of pregnancy, so the diagnosis of GDM in early pregnancy by either FPG or OGTT values is not evidence based (69).”
Method2. Classification and Diagnosis of Diabetes:Standards of Care in Diabetes—2023
ElSayed, N. A., Aleppo, G., Aroda, V. R., Bannuru, R. R., Brown, F. M., Bruemmer, D., Collins, B. S., Gaglia, J. L., Hilliard, M. E., Isaacs, D., et al. (2023) · Diabetes Care · doi:10.2337/dc23-s002 · Cited by 2,433
2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2024
American Diabetes Association Professional Practice Committee, ElSayed, N. A., Aleppo, G., Bannuru, R. R., Bruemmer, D., Collins, B. S., Ekhlaspour, L., Gaglia, J. L., Hilliard, M. E., Johnson, E. L., et al. (2024) · Diabetes Care · doi:10.2337/dc24-s002 · Cited by 2,086
2. Classification and Diagnosis of Diabetes
American Diabetes Association (2017) · Diabetes Care · doi:10.2337/dc17-s005 · Cited by 1,603
“The International Association of the Diabetes and Pregnancy Study Groups (IADPSG) GDM diagnostic criteria for the 75-g OGTT were not derived from data in the first half of pregnancy, so the diagnosis of GDM in early pregnancy by either FPG or OGTT values is not evidence based (48).”
Method2. Diagnosis and classification of diabetes: standards of care in diabetes-2025
American Diabetes Association Professional Practice Committee, ElSayed, N. A., McCoy, R. G., Aleppo, G., Balapattabi, K., Beverly, E. A., Briggs Early, K., Bruemmer, D., Ebekozien, O., Echouffo-Tcheugui, J. B., et al. (2025) · Diabetes Care · doi:10.2337/dc25-s002 · Cited by 1,393
A Clinical Update on Gestational Diabetes Mellitus
Sweeting, A., Wong, J., Murphy, H. R., & Ross, G. P. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnac003 · Cited by 928
Gestational diabetes mellitus: mechanisms, treatment, and complications
Johns, E. C., Denison, F. C., Norman, J. E., & Reynolds, R. M. (2018) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2018.09.004 · Cited by 828
2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2026
American Diabetes Association Professional Practice Committee for Diabetes*, Bajaj, M., McCoy, R. G., Balapattabi, K., Bannuru, R. R., Bellini, N. J., Bennett, A. K., Beverly, E. A., Briggs Early, K., ChallaSivaKanaka, S., et al. (2026) · Diabetes Care · doi:10.2337/dc26-s002 · Cited by 473
Epidemiology and management of gestational diabetes
Sweeting, A., Hannah, W., Backman, H., Catalano, P., Feghali, M., Herman, W. H., Hivert, M.-F., Immanuel, J., Meek, C., Oppermann, M. L., et al. (2024) · The Lancet · doi:10.1016/s0140-6736(24)00825-0 · Cited by 431
Self-citationTreatment of Gestational Diabetes Mellitus Diagnosed Early in Pregnancy
Simmons, D., Immanuel, J., Hague, W. M., Teede, H., Nolan, C. J., Peek, M. J., Flack, J. R., McLean, M., Wong, V., Hibbert, E., et al. (2023) · New England Journal of Medicine · doi:10.1056/nejmoa2214956 · Cited by 366
Immanuel, J., & Simmons, D. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0943-7 · Cited by 264
Effect of physical activity and/or healthy eating on GDM risk: The DALI Lifestyle Study
Simmons, D., Devlieger, R., van Assche, A., Jans, G., Galjaard, S., Corcoy, R., Adelantado, J. M., Dunne, F., Desoye, G., Harreiter, J., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-3455 · Cited by 225
“As the criteria for GDM diagnosis early in pregnancy may need to be higher (32), it could be argued that some women who would have benefited from the DALI intervention were excluded.”
BackgroundSelf-citationMalaza, N., Masete, M., Adam, S., Dias, S., Nyawo, T., & Pheiffer, C. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph191710846 · Cited by 195
Pathophysiology from preconception, during pregnancy, and beyond.
Hivert, M.-F., Backman, H., Benhalima, K., Catalano, P., Desoye, G., Immanuel, J., McKinlay, C. J. D., Meek, C. L., Nolan, C. J., Ram, U., et al. (2024) · The Lancet · doi:10.1016/s0140-6736(24)00827-4 · Cited by 186
Self-citationThe Oral Glucose Tolerance Test: 100 Years Later
Jagannathan, R., Neves, J. S., Dorcely, B., Chung, S. T., Tamura, K., Rhee, M., & Bergman, M. (2020) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s246062 · Cited by 152
on behalf of the DALI Core Investigator group, Egan, A. M., Vellinga, A., Harreiter, J., Simmons, D., Desoye, G., Corcoy, R., Adelantado, J. M., Devlieger, R., Van Assche, A., et al. (2017) · Diabetologia · doi:10.1007/s00125-017-4353-9 · Cited by 152
“While the diagnostic cut-off values for GDM in early pregnancy are controversial [9, 13], our findings indicate that there is some evidence that early screening in obese women”
BackgroundSelf-citationGillet, V., Ouellet, A., Stepanov, Y., Rodosthenous, R. S., Croft, E. K., Brennan, K. J. M., Abdelouahab, N., Baccarelli, A., & Takser, L. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-02693 · Cited by 145
Diabetes in pregnancy: a new decade of challenges ahead
the Diabetic Pregnancy Study Group, Schaefer-Graf, U., Napoli, A., & Nolan, C. J. (2018) · Diabetologia · doi:10.1007/s00125-018-4545-y · Cited by 118
“Diagnostic criteria for GDM have not been validated for early pregnancy, although early screening for ‘overt diabetes’ (IADPSG) or ‘diabetes in pregnancy’ (WHO) in at-risk women is recommended [61].”
Backgroundde Mendonça, E. L. S. S., Fragoso, M. B. T., de Oliveira, J. M., Xavier, J. A., Goulart, M. O. F., & de Oliveira, A. C. M. (2022) · Antioxidants · doi:10.3390/antiox11010129 · Cited by 126
Law, K. P., & Zhang, H. (2017) · Clinica Chimica Acta · doi:10.1016/j.cca.2017.02.008 · Cited by 139
Early Pregnancy Biochemical Predictors of Gestational Diabetes Mellitus
Powe, C. E. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0834-y · Cited by 119
Harreiter, J., Simmons, D., Desoye, G., Corcoy, R., Adelantado, J. M., Devlieger, R., van Assche, A., Galjaard, S., Damm, P., Mathiesen, E. R., et al. (2016) · Diabetes Care · doi:10.2337/dc16-0200 · Cited by 103
“IADPSG members now recommend that their GDM criteria should not be used in early pregnancy but have not provided alternative criteria (3).”
BackgroundSelf-citationGestational Diabetes Mellitus Screening and Diagnosis
Sert, Ü. Y., & Ozgu-Erdinc, A. S. (2020) · Advances in experimental medicine and biology · doi:10.1007/5584_2020_512 · Cited by 94
Wexler, D. J., Powe, C. E., Barbour, L. A., Buchanan, T., Coustan, D. R., Corcoy, R., Damm, P., Dunne, F., Feig, D. S., Ferrara, A., et al. (2018) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000002726 · Cited by 80
Self-citationCosson, E., Carbillon, L., & Valensi, P. (2017) · Journal of Diabetes Research · doi:10.1155/2017/8921712 · Cited by 82
“The IADPSG recommends that women with eGDM should be referred for immediate care, even if the level of proof for this recommendation is very low regarding to prognosis [12, 13].”
BackgroundInfluentialHuhn, E. A., Rossi, S. W., Hoesli, I., & Göbl, C. S. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00696 · Cited by 80
“Due to these concerns, some authors suggested that the use of the IADPSG threshold for FPG is not justified in early pregnancy and IADPSG representatives issued a statement in 2016 to discontinue use of the FPG threshold (15).”
BackgroundBhavadharini, B., Uma, R., Saravanan, P., & Mohan, V. (2016) · Clinical Diabetes and Endocrinology · doi:10.1186/s40842-016-0031-y · Cited by 75
“9 % in early pregnancy, who were at risk of developing adverse pregnancy outcomes [25].”
BackgroundCall to action for a life course approach
Simmons, D., Gupta, Y., Hernandez, T. L., Levitt, N., van Poppel, M., Yang, X., Zarowsky, C., Backman, H., Feghali, M., & Nielsen, K. K. (2024) · The Lancet · doi:10.1016/s0140-6736(24)00826-2 · Cited by 66
Dutton, H., Borengasser, S. J., Gaudet, L. M., Barbour, L. A., & Keely, E. J. (2018) · Medical Clinics of North America · doi:10.1016/j.mcna.2017.08.008 · Cited by 66
Self-citationThe treatment of booking gestational diabetes mellitus (TOBOGM) pilot randomised controlled trial
Simmons, D., Nema, J., Parton, C., Vizza, L., Robertson, A., Rajagopal, R., Ussher, J., & Perz, J. (2018) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-018-1809-y · Cited by 71
“This has led to calls not to use the 24– 28 week GDM criteria earlier in pregnancy [9].”
MethodContinuous Glucose Monitoring Profiles in Pregnancies With and Without Gestational Diabetes Mellitus
Durnwald, C. P., Beck, R. W., Li, Z., Norton, E., Bergenstal, R. M., Johnson, M. L., DUNNIGAN, S. M., Banfield, M., KRUMWIEDE, K. J., Sibayan, J., et al. (2024) · Diabetes Care · doi:10.2337/dc23-2149 · Cited by 77
Simmons, D., Hague, W. M., Teede, H. J., Cheung, N. W., Hibbert, E. J., Nolan, C. J., Peek, M. J., Girosi, F., Cowell, C. T., Wong, V. W., et al. (2018) · Medical Journal of Australia · doi:10.5694/mja17.01129 · Cited by 67
A Medically Supervised Pregnancy Exercise Intervention in Obese Women: A Randomized Controlled Trial
Daly, N., Farren, M., McKeating, A., O'Kelly, R., Stapleton, M., & Turner, M. J. (2017) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000002267 · Cited by 61
Gestational diabetes mellitus: A pragmatic approach to diagnosis and management
Nankervis, A., Price, S., & Conn, J. (2018) · Australian Journal of General Practice · doi:10.31128/ajgp-01-18-4479 · Cited by 59
Vinter, C. A., Tanvig, M. H., Christensen, M. H., Ovesen, P. G., Jørgensen, J. S., Andersen, M. S., McIntyre, H. D., & Jensen, D. M. (2018) · Diabetes Care · doi:10.2337/dc18-0808 · Cited by 57
“A later article from IADPSG stated that the diagnostic thresholds should not be directly applied to early pregnancy because of physiological changes in fasting glucose during pregnancy (6).”
BackgroundSørensen, A. E., van Poppel, M. N. M., Desoyé, G., Damm, P., Simmons, D. S., Jensen, D., Dalgaard, L. T., & The DALI Core Investigator Group (2021) · Cells · doi:10.3390/cells10010170 · Cited by 65
“Currently, no randomized controlled trials have investigated the beneficial effects diagnosing GDM prior to 24–28 weeks of gestation [12,13].”
BackgroundSelf-citationConsiderations in the Management of Gestational Diabetes Mellitus: “You Are What Your Mother Ate!”
Moses, R. G., & Cefalu, W. T. (2016) · Diabetes Care · doi:10.2337/dci15-0030 · Cited by 53
“(21) raises important issues and concerns about the early diagnosis of GDM in pregnancy.”
BackgroundGestational diabetes mellitus: Screening with fasting plasma glucose
Agarwal, M. M. (2016) · World Journal of Diabetes · doi:10.4239/wjd.v7.i14.279 · Cited by 53
Kim, W., Park, S. K., & Kim, Y. L. (2019) · PLOS ONE · doi:10.1371/journal.pone.0225955 · Cited by 52
“…recommendation is accepted by the WHO [11]and the Endocrine Society [6],but early GDM, which is a lesser degree of hyperglycemia detected during the initial prenatal visit, is highly debatable with regard to the screening time, diagnostic criteria, intensity of treatment, and risk factors [63–65].”
Global burden of early pregnancy gestational diabetes mellitus (eGDM): A systematic review
Hannah, W., Bhavadharini, B., Beks, H., Deepa, M., Anjana, R. M., Uma, R., Martin, E., McNamara, K., Versace, V., Saravanan, P., et al. (2022) · Acta Diabetologica · doi:10.1007/s00592-021-01800-z · Cited by 46
“on the grounds of insufficient evidence of benefit from earlier screening and management [14].”
BackgroundEarly Gestational Diabetes Mellitus: Diagnostic Strategies and Clinical Implications
Bhattacharya, S., Nagendra, L., Krishnamurthy, A., Lakhani, O. J., Kapoor, N., Kalra, B., & Kalra, S. (2021) · Medical Sciences · doi:10.3390/medsci9040059 · Cited by 43
“The suggestion was not backed by evidence, and the committee members later withdrew the recommendation [28].”
BackgroundFalcone, V., Kotzaeridi, G., Breil, M. H., Rosicky, I., Stopp, T., Yerlikaya-Schatten, G., Feichtinger, M., Eppel, W., Husslein, P., Tura, A., et al. (2019) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2018.0218 · Cited by 42
Edelson, P. K., James, K. E., Leong, A., Arenas, J., CAYFORD, M., Callahan, M. J., Bernstein, S. N., Tangren, J. S., Hivert, M., Higgins, J. M., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa053 · Cited by 53
Clarke, E., Cade, T. J., & Brennecke, S. (2020) · Journal of Pregnancy · doi:10.1155/2020/9083264 · Cited by 41
Evolution of Gestational Diabetes Mellitus across Continents in 21st Century
Dłuski, D. F., Ruszała, M., Rudziński, G., Pożarowska, K., Brzuszkiewicz, K., & Leszczyńska-Gorzelak, B. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph192315804 · Cited by 41
Cosson, E., Vicaut, É., Sandre-Banon, D., Gary, F., Pharisien, I., Portal, J.-J., Banu, I., Bianchi, L., Cussac-Pillegand, C., Dina, R. C., et al. (2018) · Diabetes & Metabolism · doi:10.1016/j.diabet.2018.11.006 · Cited by 45
Simmons, D. (2021) · Diabetes Care · doi:10.2337/dci20-0055 · Cited by 38
Palm, C. V. B., Glintborg, D., Kyhl, H. B., McIntyre, H. D., Jensen, R. C., Jensen, T. K., Jensen, D. M., & Andersen, M. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.04.030 · Cited by 41
Hosseini, E., Janghorbani, M., & Shahshahan, Z. (2018) · Midwifery · doi:10.1016/j.midw.2018.07.017 · Cited by 39
Carreiro, M. P., Nogueira, A. I., & Ribeiro‐Oliveira, A. (2018) · Journal of Clinical Medicine · doi:10.3390/jcm7020011 · Cited by 43
“In regard to hyperglycemia “less than overt diabetes” in early pregnancy, especially before 24 weeks of gestation, there is not enough data to propose a new classification or diagnostic cutoffs [18].”
BackgroundHigh probability of false-positive gestational diabetes mellitus diagnosis during early pregnancy
Nakanishi, S., Aoki, S., Kasai, J., Shindo, R., Obata, S., Hasegawa, Y., Mochimaru, A., & Miyagi, E. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2020-001234 · Cited by 37
“…stated that early-onset GDM may be defined as a HbA1c level of ≥ 5.9% (41 mmol/mol) in early pregnancy instead of an FPG level of 92–125 mg/ dL. 7 In the present study, HbA1c levels had been significantly higher since the baseline in the women with true GDM than in those with false positive…”
InfluentialHaque, M. M., Tannous, W. K., Herman, W. H., Immanuel, J., Hague, W. M., Teede, H., Enticott, J., Cheung, N. W., Hibbert, E., Nolan, C. J., et al. (2024) · eClinicalMedicine · doi:10.1016/j.eclinm.2024.102610 · Cited by 35
“12 Using various criteria, early GDM comprises 40 – 66% of GDM diagnoses, 13 – 15 and is associated with more adverse pregnancy outcomes 16 – 18 and insulin resistance 19 than GDM diagnosed later in pregnancy.”
Ryan, D. K., Haddow, L., Ramaesh, A., Kelly, R., Johns, E. C., Denison, F. C., Dover, A. R., & Reynolds, R. M. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.09.013 · Cited by 35
Consensus in Gestational Diabetes MELLITUS: Looking for the Holy Grail
Agarwal, M. M. (2018) · Journal of Clinical Medicine · doi:10.3390/jcm7060123 · Cited by 34
“Some experts have cogently argued that GDM in pregnancy cannot be accepted since there are no controlled trials that address the benefits of diagnosing and treating GDM in early pregnancy [40].”
BackgroundBiesty, L., Egan, A. M., Dunne, F., Dempsey, E. M., Meskell, P., Smith, V. A., Bhuinneain, G. M. N., & Devane, D. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012910 · Cited by 39
Benhalima, K., Minschart, C., Crombrugge, P. V., Calewaert, P., Verhaeghe, J., Vandamme, S., Theetaert, K., Devlieger, R., Pierssens, L., Ryckeghem, H., et al. (2019) · Acta Clinica Belgica · doi:10.1080/17843286.2019.1637389 · Cited by 35
Wu, Q., Chen, Y., Zhou, M., Liu, M., Zhang, L., Liang, Z., & Chen, D. (2022) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-022-00788-y · Cited by 31
“However, this was ultimately removed from the recommendation due to the lack of evidence for a convincing threshold in early pregnancy [37].”
BackgroundRegnault, N., Lebreton, E., Tang, L., Fosse‐Edorh, S., Barry, Y., Olié, V., Billionnet, C., Weill, A., Vambergue, A., & Cosson, E. (2024) · Diabetologia · doi:10.1007/s00125-023-06066-4 · Cited by 31
Screening for gestational diabetes in Europe: where do we stand and how to move forward?
Benhalima, K., Damm, P., Assche, A. V., Mathieu, C., Devlieger, R., Mahmood, T. A., & Dunne, F. (2016) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2016.04.002 · Cited by 36
Self-citationMetabolomics in Gestational Diabetes Mellitus: A Review
XIE, J., LI, L., & XING, H. (2023) · Clinica Chimica Acta · doi:10.1016/j.cca.2022.12.005 · Cited by 26
Cheng, X.-Y., Ji, X., Yang, D., Zhang, C., Chen, L., Liu, C., Meng, X., Wang, W., Li, H., Kan, H., et al. (2022) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2022.113278 · Cited by 27
Optimal management of gestational diabetes
Egan, A. M., & Dunne, F. (2019) · British Medical Bulletin · doi:10.1093/bmb/ldz025 · Cited by 29
Oral glucose tolerance test results in early pregnancy: A Finnish population-based cohort study
Jokelainen, M., Stach‐Lempinen, B., Rönö, K., Nenonen, A., Kautiainen, H., Teramo, K. A., & Klemetti, M. M. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108077 · Cited by 28
Salvatori, B., Linder, T., Eppel, D., Morettini, M., Burattini, L., Göbl, C. S., & Tura, A. (2022) · Cardiovascular Diabetology · doi:10.1186/s12933-022-01649-8 · Cited by 27
“In addition, though there are still controversies about optimal timing for metabolic assessment in pregnancy [20, 21], the assessment at early pregnancy (i.”
BackgroundRelationship Between Early-Pregnancy Glycemia and Adverse Outcomes: Findings From the TOBOGM Study
Sweeting, A., Enticott, J., Immanuel, J., Hague, W. M., Teede, H. J., Nolan, C. J., Peek, M. J., Flack, J. R., McLean, M. P., Wong, V., et al. (2024) · Diabetes Care · doi:10.2337/dc23-2214 · Cited by 30
Should the IADPSG criteria be applied when diagnosing early-onset gestational diabetes?
Hagiwara, Y., Kasai, J., Nakanishi, S., Saigusa, Y., Miyagi, E., & Aoki, S. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.03.048 · Cited by 24
Iwama, N., Sugiyama, T., Metoki, H., Kusaka, H., Yaegashi, N., Sagawa, N., Hiramatsu, Y., Toyoda, N., & The JAGS Group (2019) · Journal of Diabetes Investigation · doi:10.1111/jdi.13044 · Cited by 24
Gestational diabetes in the first trimester: is early testing justified?
Sweeting, A., Ross, G. P., Hyett, J. A., & Wong, J. (2017) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(17)30066-9 · Cited by 24
FIGO analysis of research priorities in hyperglycemia in pregnancy
McIntyre, D. H., Desoyé, G., Dunne, F., Siméoni, U., Visser, G. H. A., Kapur, A., & Hod, M. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.03.026 · Cited by 23
Sweeting, A., MacMillan, F., Simmons, D., & attendees, F. T. T. S. (2024) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/ajo.13823 · Cited by 21
Benhalima, K., Crombrugge, P. V., Moyson, C., Verhaeghe, J., Vandeginste, S., Verlaenen, H., Vercammen, C., Maes, T., Dufraimont, E., Block, C. E. M. D., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa831 · Cited by 23
Prognosis Associated with Sub-Types of Hyperglycaemia in Pregnancy
Cosson, E., Bentounes, S. A., Nachtergaele, C., Berkane, N., Pinto, S., Sal, M., Bihan, H., Tatulashvili, S., Portal, J.-J., Carbillon, L., et al. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10173904 · Cited by 20
“One might suppose that immediate care for eGDM and eDIP would improve prognosis, but this had not been proven at that time [6,9,15,32,33].”
BackgroundInfluentialKotzaeridi, G., Blätter, J., Eppel, D., Rosicky, I., Falcone, V., Adamczyk, G., Linder, T., Yerlikaya‐Schatten, G., Weißhaupt, K., Henrich, W., et al. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10204794 · Cited by 22
Longitudinal changes in glucose during pregnancy in women with gestational diabetes risk factors
Dratver, M. B., Arenas, J., Thaweethai, T., Yu, C. L., James, K. E., Rosenberg, E. A., Callahan, M. J., CAYFORD, M., Tangren, J. S., Bernstein, S. N., et al. (2021) · Diabetologia · doi:10.1007/s00125-021-05622-0 · Cited by 20
“pregnancy may not apply to the first trimester [4].”
BackgroundHillier, T. A., Pedula, K. L., Ogasawara, K. K., Vesco, K. K., Oshiro, C. E. S., & Marter, J. L. V. (2022) · Journal of Perinatal Medicine · doi:10.1515/jpm-2021-0581 · Cited by 20
Birukov, A., Glintborg, D., Schulze, M. B., Jensen, T. K., Kuxhaus, O., Andersen, L. B., Kräker, K., Polemiti, E., Jensen, B. L., Jørgensen, J. S., et al. (2022) · Journal of Hypertension · doi:10.1097/hjh.0000000000003196 · Cited by 19
“The GDM-WHO 2013 threshold labels a high proportion of pregnant women as having GDM, yet they may be at low risk of pregnancy complications in some populations [4,6,7].”
BackgroundRepeated oral glucose tolerance tests in women at risk for gestational diabetes mellitus
de Wit, L., Bos, D., van Rossum, A. P., van Rijn, B. B., & Boers, K. E. (2019) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2019.09.022 · Cited by 19
Bhattacharya, S., Nagendra, L., Dutta, D., Mondal, S., Bhat, S., Raj, J. M., Boro, H., Kamrul-Hasan, A. B. M., & Kalra, S. (2024) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2024.103051 · Cited by 24
Timing of diagnosis of gestational diabetes and pregnancy outcomes: A retrospective cohort
Shub, A., Chee, T., Templeton, A., Boyce, D. J., McNamara, C., Houlihan, C. A., Churilov, L. P., & McCarthy, E. A. (2018) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/ajo.12814 · Cited by 18
Jamieson, E. L., Spry, E. P., Kirke, A. B., Griffiths, E. K., Porter, C., Roxburgh, C., Singleton, S., Sterry, K., Atkinson, D. N., & Marley, J. V. (2021) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2021.108868 · Cited by 19
Singh, C., Gupta, Y., Goyal, A., Kalaivani, M., Garg, V., Bharti, J., Singhal, S., Kachhawa, G., Kulshrestha, V., Kumari, R., et al. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108409 · Cited by 18
Amylidi-Mohr, S. K., Lang, C., Mosimann, B., Fiedler, M., Stettler, C., Surbek, D., & Raio, L. (2022) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/aogs.14495 · Cited by 19
SCOTT, E. M., Murphy, H. R., Myers, J., Saravanan, P., Poston, L., & Law, G. R. (2023) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-023-05824-x · Cited by 19
Variation in the classification of hyperglycaemia in pregnancy and its implication
Gupta, Y., Goyal, A., Kalra, S., & Tandon, N. (2020) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(20)30018-8 · Cited by 16
Gupta, Y., Kapoor, D., Josyula, L. K., Praveen, D., Naheed, A., Desai, A. K., Pathmeswaran, A., de Silva, H. A., Lombard, C. B., Alam, D. S., et al. (2018) · Diabetic Medicine · doi:10.1111/dme.13850 · Cited by 15
Cosson, E., Vicaut, É., Berkane, N., Cianganu, T.-L., Baudry, C., Portal, J.-J., Boujenah, J., Valensi, P. E., & Carbillon, L. (2020) · Diabetes & Metabolism · doi:10.1016/j.diabet.2020.08.007 · Cited by 17
Survey on testing for gestational diabetes mellitus in Australia
Flack, J. R., & Ross, G. P. (2016) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/ajo.12457 · Cited by 14
Intermediate hyperglycemia in early pregnancy: A South Asian perspective
Punnose, J., Sukhija, K., & Rijhwani, R. M. (2023) · World Journal of Diabetes · doi:10.4239/wjd.v14.i5.573 · Cited by 14
Current approach to early gestational diabetes mellitus: A clinical update
Goyal, A., & Gupta, Y. (2025) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2025.103256 · Cited by 13
Wu, D., Zhang, J., Xiong, Y.-M., Wang, H., Lu, D., Guo, M., Zhang, J., Chen, L., Fan, J., Huang, H., et al. (2022) · Nutrients · doi:10.3390/nu14163295 · Cited by 14
“60 mM should be provided with nutrition and exercise advice in Chinese population [24,26,27].”
BackgroundPunnose, J., Malhotra, R. K., Sukhija, K., Rijhwani, R. M., Choudhary, N., Sharma, A., Vij, P., & Bahl, P. (2022) · Diabetic Medicine · doi:10.1111/dme.14993 · Cited by 16
Universal screening for hyperglycemia in early pregnancy and the risk of adverse pregnancy outcomes
Shen, L., Zhang, S., Wen, J., Liu, J., Lin, X., Zhu, C., Cai, S., Xie, L., Wang, Z., & Chen, H. (2025) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-025-07253-4 · Cited by 15
“The IADPSG initially recommended that an FPG value of 5.1–6.9 mmol/l before 24 weeks of gestation be classified as GDM and later reversed this recommendation based on studies focused on the outcome of GDM [7].”
InfluentialPredictors of later insulin therapy for gestational diabetes diagnosed in early pregnancy
Tamagawa, M., Kasuga, Y., Saisho, Y., Tanaka, Y., Hasegawa, K., Oishi, M., Endo, T., Sato, Y., Ikenoue, S., Tanaka, M., et al. (2021) · Endocrine Journal · doi:10.1507/endocrj.ej21-0118 · Cited by 14
“1 mmol/L (92 mg/dL) in the first trimester as E-GDM based on some current evidence [27].”
MethodHarreiter, J., Desoyé, G., van Poppel, M. N. M., Kautzky‐Willer, A., Dunne, F., Corcoy, R., Devlieger, R., Simmons, D. S., Adelantado, J. M., Damm, P., et al. (2019) · Current Diabetes Reports · doi:10.1007/s11892-019-1282-7 · Cited by 13
Self-citation[Prevention of fentanyl rebound by administration of cimetidine (author's transl)].
Lauven, P. M., Stoeckel, H., Schüttler, J., & Schwilden, H. (1981) · Der Anaesthesist · Cited by 12
Scifres, C., & Lowe, W. L. (2024) · Diabetes Care · doi:10.2337/dci24-0036 · Cited by 12
Metadata
- Authors
- McIntyre, H. D., Sacks, D. A., Barbour, L. A., Feig, D. S., Catalano, P. M., Damm, P., & McElduff, A.
- Affiliations
- Mater Research, The University of Queensland, Brisbane, Queensland, Australia
- Kaiser Permanente (US)
- University of Colorado Denver (US)
- University of Toronto (CA)
- MetroHealth (US)
- University of Copenhagen (DK)
- The University of Sydney (AU)
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2015-10-30
- Volume
- 39
- Issue
- 1
- Pages
- 53-54
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W1872548695
- Cited by
- 181
- References
- 6
- Citations by year
- 2026: 7 · 2025: 13 · 2024: 24 · 2023: 8 · 2022: 26 · 2021: 21 · 2020: 19 · 2019: 17 · 2018: 24 · 2017: 11 · 2016: 9 · 2015: 1
- FWCI
- 17.07
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- hyperglycemia in pregnancy, early pregnancy, IADPSG criteria, diabetes in pregnancy, overt diabetes, gestational diabetes mellitus, HbA1c, fasting blood glucose, random blood glucose, diagnostic thresholds
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.